While details of Camp Lejeune offers and settlements will not be publicly reported, the U.S. government must keep settlement masters and key members of the litigation updated.
Parties have agreed on what plaintiffs need to prove in the first Camp Lejeune bellwether trials, after negotiations for a global settlement have failed so far
The U.S. Navy has only made Camp Lejeune settlement offers to a small fraction of the more than 300,000 water contamination injury claims presented by Marine veterans and family members injured at the base.
As the filing deadline for Camp Lejeune lawsuits approach, parties are looking at both settlement options and a series of bellwether trials to resolve the litigation.
Nearly two years after the Camp Lejeune Justice Act was enacted, the U.S. government has only identified 136 claims that may be eligible for an elective settlement offer.
Lawyers will select 25 Camp Lejeune lawsuits involving kidney cancer, bladder cancer, leukemia, non-Hodgkin's lymphoma or Parkinson's disease from a group of 100 eligible cases, which will be prepared for a series early test trials.
Judges overseeing the Camp Lejeune lawsuits will hear proposals from the U.S. government and plaintiff's leadership counsel over which illnesses and diseases should be selected for a third round of bellwether trials.
Four out of 10 nursing home residents face overtreatment for diabetes, putting them at risk of dangerously low blood sugar levels.
